Chronic fatigue syndrome: An update for psychiatrists
Camila Prochalska, Florence Gressier, Emmanuelle Corruble
DOI: 10.4236/ojpsych.2012.21007   PDF   HTML     6,248 Downloads   11,273 Views   Citations


Chronic fatigue syndrome (CFS) is a poorly understood condition primarily characterized by debilitateing, persistent or recurrent fatigue, increased physical and mental fatigability, cognitive impairment and widespread musculoskeletal pain. During the past two decades, there have been heated debates about CFS among researchers, practitioners and patients. The existence of the disorder has been questioned, its underlying pathophysiology debated and an effective treatment opposed (such as antidepressants, stimulants or antibiotics). A lot of multidisciplinary literature is found about CFS, but to date, many psychiatrists seem to unknown the existence of this illness or think that it is a purely psychological disorder. However, CFS is sitting on the border between medicine and psychiatry. The aim of this review is to make psychiatrists aware of the existence of CFS and that they will, one day, be confronted with the management of this illness. Thus, this update allows understanding what is CFS, the diversity of physiopathology underlined and its management.

Share and Cite:

Prochalska, C. , Gressier, F. and Corruble, E. (2012) Chronic fatigue syndrome: An update for psychiatrists. Open Journal of Psychiatry, 2, 40-48. doi: 10.4236/ojpsych.2012.21007.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Wyller, V.B. (2007) The chronic fatigue syndrome-an update. Acta Neurologica Scandinavica, 115, 7-14. doi:10.1111/j.1600-0404.2007.00840.x
[2] Prins, J.B., Van der Meer, J.W.M. and Bleijenberg G. (2006) Chronic fatigue syndrome. Lancet, 367, 346-355. doi:10.1016/S0140-6736(06)68073-2
[3] Orth, J.P. (1993) La fatigue au quotidien. Sante Edition Odile Jacob, 103-115.
[4] Rouillon, F., Delhommeau, G. and Vinceneux, P. (1996) Le syndrome de fatigue chronique, Masson, Paris.
[5] Fukuda, K., Straus, S.E., Hickie, I., Sharp, M.C., Dobbins, J.C. and Komaroff, A. (1994) The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121, 953-959.
[6] Harvey, S.B. and Wessely, S. (2009) Chronic fatigue syndrome: Identifying zebras amongst the horses. BMC Medicine, 7, 58. doi:10.1186/1741-7015-7-58
[7] Wojcik, W., Armstrong, Kanaan, R. (2011) Chronic fatigue syndrome: labels, meanings and consequences. Journal of Psychosomatic Research, 70, 500-504. doi:10.1016/j.jpsychores.2011.02.002
[8] Van Houdenhove, B., Pae, C.U. and Luyten, P. (2010) Chronic fatigue syndrome: Is there a role for non-anti- depressant pharmacotherapy? Expert Opinion, 11, 215-223. doi:10.1517/14656560903487744
[9] Boneva, R.S., Maloney, E.M., Lin, J.M., et al. (2011) Gynecological history in chronic fatigue syndrome: A population-based case-control study. Journal of Women’s Health, 20, 1. doi:10.1089/jwh.2009.1900
[10] Bhui, K.S., Dinos, S., Ashby, D., Nazroo, J., Wessely, S. and White, P.D. (2011) Chronic fatigue syndrome in an ethnically diverse population: The influence of psychosocial adversity and physical inactivity. BMC Medicine, 9, 26. doi:10.1186/1741-7015-9-26
[11] Nater, U.M., Jones, J.F., Lin, J.M.S, Maloney, E., Reeves, W.C. and Heim, C. (2010) Personality features and personality disorders in chronic fatigue syndrome: A population-based study. Psychotherapy and Psychosomatics, 79, 312-318. doi:10.1159/000319312
[12] Jason, L.A., Richman, J.A., Rademaker, A.W., et al. (1999) A community-based study of chronic fatigue syn- drome. Archives of Internal Medicine, 159, 2129-2137. doi:10.1001/archinte.159.18.2129
[13] Afari. N. and Buchwald, D. (2003) Chronic fatigue syndrome: A review. American Journal of Psychiatry, 160, 221-236. doi:10.1176/appi.ajp.160.2.221
[14] Fernandez, A.A., Martin, A.P., Martinez, M.I., et al. (2009) Chronic fatigue syndrome: Aetiology, diagnosis and treatment. BMC psychiatry, 9, S1. doi:10.1186/1471-244X-9-S1-S1
[15] Constant, E.I., Adam, S., Gillain, B., Lambert, M., Masquelier, E. and Seron, X. (2011) Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls. Clinical Neurology Neurosurgery, 113, 295-302. doi:10.1016/j.clineuro.2010.12.002
[16] Schrijvers, D., Van Den Eede, F., Maas, Y., Cosyns, P., Hulstijn, W. and Sabbe, B.G.C. (2009) Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: A comparative study. Journal of Affective Disorders, 115, 46-53. doi:10.1016/j.jad.2008.08.010
[17] Goodwin, L., White, P.D., Hotopf, M., Stanfeld, S.A. and Clark, C. (2011) Psychopathology and physical activity as predictors of chronic fatigue syndrome in the 1958 british birth cohort: A replication study of the 1946 and 1970 birth cohorts. Annals of Epidemiology, 21, 343-350. doi:10.1016/j.annepidem.2010.12.003
[18] Brown, M.M., Brown, A.A. and Jason, L.A. (2010) Illness duration and coping style in chronic fatigue syndrome. Psychological Reports, 106, 383-393. doi:10.2466/pr0.106.2.383-393
[19] Aaron, L.A., Burke, M.M. and Buchwald, D. (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorder. Archives of Internal Medicine, 160, 221-227. doi:10.1001/archinte.160.2.221
[20] Sullivan, A., Nord, C.E. and Evengard, B. (2009) Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutrition Journal, 8, 4. doi:10.1186/1475-2891-8-4
[21] Kato, K., Sullivan, P.F., Evengard, B. and Pedersen, N.L. (2006) Premorbid predictors of chronic fatigue. Archives of General Psychiatry, 63, 1267-1272.
[22] Cho, H.J., Skowera, A., Cleare, A. and Wessely, S. (2006) Chronic fatigue syndrome: An update focusing on phenomenology and pathophysiology. Current Opinion in Psychiatry, 19, 67-73. doi:10.1097/01.yco.0000194370.40062.b0
[23] Albright, F., Light, K., Light, A., Bateman, .L and Cannon-Albright, L.A. (2011) Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurology, 11, 62. doi:10.1186/1471-2377-11-62
[24] Narita, M., Nishigami, N. and Narita, N. (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochemical and Biophysical Research Communications, 311, 264-266. doi:10.1016/j.bbrc.2003.09.207
[25] Saiki, T., Kawai, T., Morita, K., et al. (2008) Identification of marker genes for differential diagnosis of chronic fatigue syndrome. Molecular Medicine, 14, 599-607. doi:10.2119/2007-00059.Saiki
[26] de Lange, F.P., Kalkman, J.S., Bleijenberg, G., et al. (2005) Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage, 26, 777-781. doi:10.1016/j.neuroimage.2005.02.037
[27] Lange, G., Steffner, T.J. and Cook, D.B., et al. (2005) Objective evidence of cognitive complaints in chronic fatigue syndrome: A Blod fMRI study of verbal working memory. Neuroimage, 26, 513-524. doi:10.1016/j.neuroimage.2005.02.011
[28] Natelson, B.H., Cohen, J.M., Brasloff, I. and Lee, H.J. (1993) A controlled study of brain magnectic resonance imaging in patients with fatiguing illnesses. Journal of the Neurological Sciences, 120, 213-217. doi:10.1016/0022-510X(93)90276-5
[29] Lange, G., Deluca, J., Maldijian, J.A., Lee, H.J., Tiersky, L.A. and Natelson, B.H. (1999) Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. Journal of the Neurological Sciences, 171, 3-7. doi:10.1016/S0022-510X(99)00243-9
[30] Hooper, M. (2007) Myalgic encephalomyelitis: A review with emphasis on key findings in biomedical research. Journal of Clinical Pathology, 60, 466-471. doi:10.1136/jcp.2006.042408
[31] Morinet, F. and Corruble, E. (in press) Chronic fatigue syndrome and viral infections. In: “Chronic Fatigue Syndrome,” InTech, Rijeka, Croatia.
[32] Cameron, B., Hirschberg, D.L., Rosenberg-Hassan, Y., Ablashi, D. and Lloyd, A. (2010). Serum cytokine levels in postinfective fatigue syndrome. Clinical Infectious Diseases, 50, 278-280.
[33] Lombardi, V.C., Ruschetti, F.W., Das Gupta, J., et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 326, 585-589. doi:10.1126/science.1179052
[34] Van Kuppeveld, F.J.M., De Jong, A.S., Lanke, K.H., et al. (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: Retrospective analysis of samples from an established cohort. British Medical Journal, 340, c1018. doi:10.1136/bmj.c1018
[35] Satterfield, B.C., Garcia, R.A., Jia, H., Tang, S., Zheng, H. and Switzer, W.M. (2011) Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology, 8, 12. doi:10.1186/1742-4690-8-12
[36] Furuta, R.A., Miyazawa, T., Sugiyama, T., et al. (2011) No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology, 8, 20. doi:10.1186/1742-4690-8-20
[37] Groom, H.C.T., Boucherit, V.C., Makinson, K., et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology, 7, 10. doi:10.1186/1742-4690-7-10
[38] Switzer, W.M., Jia, H., Hohn, O., et al. (2010) Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection I persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology, 7, 57. doi:10.1186/1742-4690-7-57
[39] Lo, S-C., Pripuzova, N. and Li, B., et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proceedings of the National Academy of Sciences, 107, 36. doi:10.1073/pnas.1012780107
[40] Fletche, M.A., Zeng, X.R., Maher, K., et al. (2010) Biomarkers in chronic fatigue syndrome: evaluation of natural killer, cell function and dipeptidyl peptidase IV/CD26. Plos One, 5, e10817.
[41] Withehead, W.E., Palsson, O. and Jones, K.R. (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology, 122, 1140-1156. doi:10.1053/gast.2002.32392
[42] Reyes, M., Dobbins, J.G., Mawle, A.C., et al. (1996) Risk factors for CFS: A case control study. Journal of Chronic Fatigue Syndrome, 2, 17-33. doi:10.1300/J092v02n04_03
[43] Moorkens, G., Wynants, H. and Abs, R. (1998) Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study. Growth Hormone & IGF Research, 8, 131-133.
[44] Vercoulen, J.H., Swanink, C.M., Zitman, F.G., et al. (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet, 374, 858-861. doi:10.1016/S0140-6736(96)91345-8
[45] Forsyth, L.M. and Preuss, H.G (1999) Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Annals of Allergy, Asthma, and Immunology, 82, 185-191.
[46] Alegre. J., Roses, J.M., Javierre, C., Ruiz-Baques. A., Segundo, M.J. and De Sevilla, T.F. (2010) Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome. Revista Clínica Espanola, 210, 284-288. doi:10.1016/j.rce.2009.09.015
[47] Sathyapalan, T., Beckett, S., Rigby, A.S., Mellor, D.D. and Atkin, S.L. (2010) High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutrition Journal, 9, 55. doi:10.1186/1475-2891-9-55
[48] White, P.D., Goldsmith, K.A., Johnson, A.L., et al. (2011) Comparison of adaptive pacing therapy, cognitive behavior therapy, graded exercise therapy and specialist medical care for chronic fatigue syndrome (PACE): A randomized trial. Lancet, 377, 823-836. doi:10.1016/S0140-6736(11)60096-2
[49] Chambers, D., Bagnal, A.M., Hempel, S. and Forbes, C. (2006) Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: An update systematic review. Journal of the Royal Society of Medicine, 99, 506-520. doi:10.1258/jrsm.99.10.506
[50] Deale, A., Chalder, T., Marks, I. and Wessely, S. (1997) Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial. American Journal of Psychiatry, 154, 408-414.
[51] Nye, F. (2007) NICE clinical guideline 53—Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy).
[52] Van Houdenhove, B. and Luyten, P. (2009) Treatment of chronic fatigue syndrome: How to find a “new equilibrium”? Patient Education and Counseling, 77, 153-154. doi:10.1016/j.pec.2009.09.001

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.